TONIX PHA.NEW2024 DL-,001 revenue for the last year amounted to 3.42 M EUR, the most of which — 7.04 M EUR — came from its highest performing source at the moment, Therapeutics. The greatest contribution to the revenue figure was made by United States — last year it brought TONIX PHA.NEW2024 DL-,001 7.04 M EUR, and the year before that — 0.00 EUR.